SEC Form 4 · accession 0001179110-15-014555
MADRIGAL PHARMACEUTICALS, INC. · MDGL
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Scott D Morenstein
Director
Period of report
Nov 3, 2015
Accepted (ET)
Nov 5, 2015 · 6:40 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001157601
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Non-Employee Director Stock Option (Right to Buy)F1 | $0.67 | Nov 3, 2015 | A | 40,000 | A | — | Nov 3, 2025 | Common Stock | 40,000 | 40,000 | D |
Explanation of responses
- F11. The option vests as to 25% of the shares on November 3, 2016 and as to an additional 6.25% of the shares on the last day of each successive three-month period thereafter.